Place Raymond Blyckaerts, 13
B-1050 Brussels, Belgium

Opening hours:
Mon to Thu: 10h - 12h30 and 13h30 - 17h
Fri: 10h - 12h30 and 13h30 - 16h

Google maps

Find us on
Google Maps
To subscribe to our newsletter, please click here. If you would like to become an EATG member, please fill in the form here. You can also subscribe to our RSS feed by clicking here.
You can also follow us on one of these media :

HIV patients starting new ART can omit nucleoside reverse transcriptase inhibitors

Treatment-experienced HIV patients starting a new, optimized salvage antiretroviral therapy (ART) regimen can safely omit nucleoside reverse transcriptase inhibitors (NRTIs) under certain conditions, according to new research from the AIDS Clinical Trials Group. For NRTIs to be skipped, the cumulative activity of the new regimen has to exceed that of two fully active agents according...


Source Source: Medscape

Tags: Treatment

TAG: Tuberculosis research funding crisis imperils elimination goal

CAPE TOWN, SOUTH AFRICA, NOVEMBER 30, 2015—Worldwide funding for tuberculosis (TB) research fell $1.3 billion short of global targets in 2014, according to a report released today by Treatment Action Group (TAG). Total funding of US$674,036,492 in 2014 amounted to barely one-third of the US$2 billion experts estimate the world must spend on TB research and development (R&D) each...


Barriers to progress – Treatment activists’ response to WHO HIV treatment guidelines 2015

On World AIDS Day 2015, treatment activists celebrate the achievements made in the global fight against AIDS. Ambitious goals have been set that aim to achieve 90% of people living with HIV knowing their status, 90% of those who know their HIV status being on sustained antiretroviral therapy and 90% of those to be virally suppressed by 2020. The 2015 World Health Organization (WHO)...


Source Source: ITPC

MSF: Antiretroviral drugs fail to consistently reach patients in countries most affected by HIV/AIDS

Stock outs need to be urgently tackled to allow acceleration of the fight against HIV/AIDS Johannesburg/Harare, November 30th 2015 – The international medical organization Doctors Without Borders/Médecins Sans Frontières (MSF) today warned that lifesaving antiretroviral medicines (ARVs) are routinely not making their way to patients in sub-Saharan Africa, most...


UN-Habitat and UNAIDS present Ending the AIDS epidemic: the advantage of cities at the Africities Summit

Cities have a primary role to play to Fast-Track the end of the AIDS epidemic by 2030 says a report by UN-Habitat and UNAIDS. Ending the AIDS epidemic: the advantage of cities was presented at the Africities Summit, held in Johannesburg, South Africa. The summit, held every three years, marks a critical time as cities enter the new era of the Sustainable Development Goals....


Source Source: UNAIDS